COVID-19: Discovery, diagnostics and drug development is a research paper published in Journal of Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 454 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIAID NIH HHS
Grant: P30 AI050409
NIAID NIH HHS
Grant: R01 AI141327
National Science Foundation
Grant: 2032273
EAGER: Coronavirus infection of human lung epithelium and leukocytes: mechanisms and treatment
National Institutes of Health
Grant: 5R01AI141327-07
Structural and Chemical Analysis of Highly Potent ALLINI Platform
National Institutes of Health
Grant: 5P30AI050409-20
Center for AIDS Research at Emory University
National Institutes of Health
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of The attitudes of psychiatric patients towards COVID-19 vaccination in China: a cross-sectional study
Additional file 1 of The attitudes of psychiatric patients towards COVID-19 vaccination in China: a cross-sectional study
Additional file 2 of The attitudes of psychiatric patients towards COVID-19 vaccination in China: a cross-sectional study
Additional file 2 of The attitudes of psychiatric patients towards COVID-19 vaccination in China: a cross-sectional study
Additional file 1 of Development and validation of a PCR-free nucleic acid testing method for RNA viruses based on linear molecular beacon probes
Additional file 1 of Development and validation of a PCR-free nucleic acid testing method for RNA viruses based on linear molecular beacon probes
Additional file 1 of Knowledge, attitudes and practices towards community-acquired pneumonia and COVID-19 among general population: a cross-sectional study
Additional file 1 of Knowledge, attitudes and practices towards community-acquired pneumonia and COVID-19 among general population: a cross-sectional study